Needham analyst Alex Henderson downgrades KnowBe4 (NASDAQ:KNBE) from Buy to Hold.
Aileron Therapeutics Announces Oral Presentation Of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles And Their Stem Cells From Chemotherapy-Induced Damage At The European Society For Dermatological Research Annual Meeting 2022
New ex vivo data demonstrates protection against cyclophosphamide-induced damage to hair follicles and their stem cells
Encore presentation of data presented at Society for Investigative Dermatology in May